INDP

NASD Indaptus Therapeutics, Inc.
Oct 7, 2026 · 4:54 AM ET LAST TRADE Market Closed

$2.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.59

YTD change
-11.00%
vs 20-day SMA
-15.94%
vs 200-day SMA
+13.95%

Price ranges

Previous day
$2.39 $2.61
open $2.51 close $2.59
+$0.08 (+3.19%)
Today
$0.00 $0.00
$2.59
Past week
$1.94 $2.91
from $2.85 now $2.59
-$0.26 (-9.12%)
Past month
$1.85 $4.22
from $1.85 now $2.59
+$0.74 (+40.00%)
This year
$0.92 $5.96
from $2.91 now $2.59
-$0.32 (-11.00%)

Price & Performance

+0.99 (+61.87%) / 6M

$0.6310$2.11$3.58$5.06Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.7% away from all-time highs of $807.24
  • INDP is down 11% since the beginning of the year
  • INDP is down 30% over the past 12 months
  • INDP is up 40% over the past 1 month
  • 2% of all INDP investors are betting against INDP

INDP reads neutral: price sits above one of the two key moving averages, the 12-month move is -29.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.02
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $279.9M
Beta 0.91

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$11.6M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $397.8M

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,157.49 +1.26%
JNJ Johnson & Johnson $254.78 +0.73%
ABBV AbbVie, Inc. $266.69 +0.35%
MRK Merck & Co., Inc. $141.94 +1.72%
RHHVF Roche Holding Ltd $427.38 -0.12%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.